Table 1 Demographic and clinical characteristics of the Kawasaki Disease study population
| Â | N (%)a |
|---|---|
Demographic | |
 Sex | |
  Male | 125 (57.3) |
  Female | 93 (42.7) |
 Age | |
   < 1 year | 27 (12.3) |
  1–4 year | 116 (52.7) |
  5–9 year | 68 (30.9) |
  10–14 year | 9 (4.1) |
Clinical features | |
 Fever | |
   ≥ 5 days | 195 (98) |
  4 days | 2 (1) |
   < 4 days | 2 (1) |
 Skin rash | 184 (88.7) |
 Oral changes | 187 (86.2) |
 Nonpurulent conjunctivitis | 153 (72.9) |
 Extremity swelling/erythema | 124 (56.9) |
 Extremity desquamation | 119 (54.6) |
 Cervical lymphadenopathy | 88 (42.5) |
 BCGb site inflammation | 1 (0.5) |
Treatment | |
 Received IVIG | 191 (86.8) |
  IVIG resistant | 23 (12) |
 Received aspirin | 209 (96) |
 Received steroid | 17 (7.7) |
 Received biological | 1 (0.5) |
Complications | |
 Recurrence rate | 4 (1.8) |
 Coronary artery aneurysm | 13 (6) |
 Death | 1 (0.5) |